Univest
Univest
  • Markets

4 Debt-Free Penny Stocks to Watch in 2027

  • November 20, 2026
  • Posted by: Ankit Jaiswal
  • Category: Market
No Comments
4 Debt-Free Penny Stocks to Watch in 2027: DEN Networks, Grauer & Weil, Syncom Formulations and Fineotex

DEN Rs 25.21, Grauer & Weil Rs 76.27, Syncom Rs 22.09, Fineotex Rs 45.04 (19 Nov 2026). Debt-to-equity 0.00 to 0.03 for all four.

Quick Answer

DEN Networks, Grauer & Weil (India), Syncom Formulations and Fineotex Chemical are four debt-free penny stocks under Rs 100, with debt-to-equity ratios between 0.00 and 0.03. Syncom grew FY26 profit 54.6% to Rs 76.44 crore, and Fineotex’s September quarter profit rose 70.8%. Grauer & Weil has doubled annual profit since FY22, and DEN Networks trades at just 0.31 times book value. No debt means no interest burden, though it does not remove business or price risk.

Debt is one of the most common reasons small companies fail. Interest costs eat into profits during slow years, and lenders can force asset sales. Companies that carry no debt avoid that pressure entirely.

The four debt-free penny stocks in this article all have a debt-to-equity ratio of 0.03 or lower, trade under Rs 100, and reported profits in every one of the last five quarters. Prices are as of the 19 November 2026 NSE close, with financials from company exchange filings.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Which Penny Stocks Have Zero Debt and Steady Profits?
    • 1. DEN Networks: Zero Debt and a P/B of 0.31
    • 2. Grauer & Weil (India): Annual Profit Doubled Since FY22
    • 3. Syncom Formulations: FY26 Profit Up 54.6% With ROE of 20.34%
    • 4. Fineotex Chemical: Debt-to-Equity of 0.01 and Revenue Up 169%
  • Why Debt-Free Penny Stocks Are Safer Than Most
  • How to Find Zero Debt Penny Stocks
  • Points to Be Careful About
  • How to Invest in Debt-Free Stocks Under Rs 100
  • Conclusion
  • Frequently Asked Questions on Debt-Free Penny Stocks
    • Which are the best debt-free penny stocks in India?
    • Why should I prefer zero debt penny stocks?
    • Is DEN Networks a good value stock?
    • What does Syncom Formulations do?
    • Can debt-free companies still be risky?
    • How do I check if a stock is debt free?

Which Penny Stocks Have Zero Debt and Steady Profits?

DEN Networks, Grauer & Weil (India), Syncom Formulations and Fineotex Chemical are debt-free penny stocks that have reported a profit in each of the last five quarters. Their businesses range from cable distribution to speciality chemicals and pharmaceuticals.

Company Sector CMP (Rs) Market Cap (Rs Cr) P/E Industry P/E ROE Debt-to-Equity
DEN Networks Cable Distribution 25.21 1,200 8.11 27.13 3.88% 0.00
Grauer & Weil (India) Speciality Chemicals and Lubricants 76.27 3,451 22.19 33.29 13.71% 0.02
Syncom Formulations (India) Pharmaceuticals 22.09 2,076 21.66 40.13 20.34% 0.03
Fineotex Chemical Speciality Chemicals 45.04 5,248 31.52 33.29 13.35% 0.01

Syncom Formulations has the highest return on equity at 20.34%, while DEN Networks has the lowest P/E at 8.11 against an industry P/E of 27.13. Grauer & Weil and Fineotex both have promoter holdings above 60%.

1. DEN Networks: Zero Debt and a P/B of 0.31

DEN Networks carries a debt-to-equity ratio of 0.00 and trades at just 0.31 times its book value of Rs 80.84 per share. The company has reported a profit in each of the last five quarters, with September 2026 quarter profit of Rs 36.77 crore, up 4.5% from Rs 35.17 crore a year earlier.

DEN distributes cable television and broadband services, and Jio group entities hold 74.9% of the company. At Rs 25.21 the stock trades at a P/E of 8.11. Be careful with growth expectations: revenue has been broadly flat at around Rs 293 crore a quarter and FY26 profit of Rs 165.77 crore was below FY25, so DEN suits value-focused investors more than growth seekers.

2. Grauer & Weil (India): Annual Profit Doubled Since FY22

Grauer & Weil (India) has doubled annual profit from Rs 78.77 crore in FY22 to Rs 164.03 crore in FY26, while revenue grew from Rs 782.11 crore to Rs 1,239.78 crore. Profit has risen every year over this period. September 2026 quarter revenue rose 11.7% to Rs 337.84 crore.

The company makes surface finishing chemicals, paints and lubricants under the Growel brand. Its debt-to-equity ratio is 0.02, return on equity is 13.71% and the promoter group holds 69.04%. At Rs 76.27, the stock trades at a P/E of 22.19 against an industry P/E of 33.29 and pays a 1.31% dividend yield. Quarterly profit eased to Rs 33.69 crore from Rs 38.57 crore, so margins are worth watching.

Find Debt-Free Stocks Under Rs 100 on the Univest Screener

3. Syncom Formulations: FY26 Profit Up 54.6% With ROE of 20.34%

Syncom Formulations grew FY26 net profit by 54.6% to Rs 76.44 crore, and annual profit has nearly quadrupled from Rs 19.79 crore in FY22. In the September 2026 quarter, profit rose 60.5% to Rs 26.65 crore and revenue rose 16.7% to Rs 148.21 crore.

The pharmaceutical formulations maker has lifted operating margin to 26.73% from 19.43% a year earlier. Debt-to-equity is 0.03 and return on equity is 20.34%, the highest in this list. At Rs 22.09, the stock trades at a P/E of 21.66, about half the pharma industry P/E of 40.13. The promoter family holds 50.57%.

4. Fineotex Chemical: Debt-to-Equity of 0.01 and Revenue Up 169%

Fineotex Chemical grew September 2026 quarter revenue by 169.1% to Rs 391.41 crore and profit by 70.8% to Rs 44.55 crore, funding this expansion with a debt-to-equity ratio of just 0.01. FY26 revenue rose 44.4% to Rs 805.30 crore.

Fineotex supplies speciality chemicals for textile processing, cleaning and hygiene. The founding family holds 62.3%. At Rs 45.04 the stock trades at a P/E of 31.52, close to the industry P/E of 33.29, with a return on equity of 13.35% and a 1.00% dividend yield. Operating margin has narrowed to 16.34% as revenue scaled up, so watch whether it steadies.

Download the Univest iOS App or Univest Android App to track these debt-free stocks live and get daily research.

Why Debt-Free Penny Stocks Are Safer Than Most

Debt-free penny stocks do not pay interest, so more of their operating profit reaches shareholders. They also face no risk of lenders forcing restructuring, which has been the main cause of value loss in many low-priced stocks over the past decade.

A clean balance sheet also gives management room to invest when opportunities arise. Fineotex, for example, has more than doubled quarterly revenue without adding meaningful debt. Investors who want a broad comparison can track these stocks against the Nifty 500.

How to Find Zero Debt Penny Stocks

  • Debt-to-equity close to zero: Filter for ratios below 0.1 on a screener.
  • Consistent profits: Zero debt helps most when the business is also profitable every quarter.
  • Return on equity: A high ROE without debt, like Syncom’s 20.34%, shows strong underlying returns.
  • Promoter commitment: High promoter holding, as with Grauer & Weil at 69.04%, aligns owners with shareholders.
  • Growth or value fit: Decide whether you want growth (Fineotex, Syncom) or value (DEN Networks).

Points to Be Careful About

  • Flat revenue at DEN Networks: Low valuation reflects limited growth so far.
  • Margin trends: Fineotex and Grauer & Weil have both seen margins ease recently.
  • Small size: All four have market capitalisations below Rs 6,000 crore, which can mean lower liquidity.

How to Invest in Debt-Free Stocks Under Rs 100

  1. Use the Univest Screener to filter stocks under Rs 100 with debt-to-equity below 0.1.
  2. Check five quarters of profit for consistency.
  3. Compare P/E and ROE with industry averages.
  4. Review promoter holding and any pledged shares.
  5. Invest through a SEBI-registered broker such as Univest, in stages.

Conclusion

DEN Networks, Grauer & Weil (India), Syncom Formulations and Fineotex Chemical show that debt-free penny stocks can also deliver steady profits. Syncom and Fineotex offer the strongest growth, Grauer & Weil a long record of rising profit, and DEN Networks a deep discount to book value. With no interest burden, the main factors to track are margins and revenue growth. Review results each quarter and consult a SEBI-registered advisor before investing.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

Frequently Asked Questions on Debt-Free Penny Stocks

Which are the best debt-free penny stocks in India?

Ans. DEN Networks, Grauer & Weil (India), Syncom Formulations and Fineotex Chemical are four debt-free penny stocks with debt-to-equity ratios between 0.00 and 0.03. All four have reported a profit in each of the last five quarters. Syncom grew FY26 profit 54.6%, Fineotex grew September quarter profit 70.8%, Grauer & Weil has doubled profit since FY22, and DEN Networks trades at 0.31 times book value.

Why should I prefer zero debt penny stocks?

Ans. Zero debt penny stocks avoid interest costs and the risk of lenders forcing restructuring, which has hurt many low-priced companies in the past. More of their operating profit reaches shareholders, and they can invest in growth without depending on loans. This does not remove business risk, so you still need to check revenue growth, margins and valuation before buying. Debt-free status is a strong filter, not a full investment case.

Is DEN Networks a good value stock?

Ans. DEN Networks trades at Rs 25.21, which is 0.31 times its book value of Rs 80.84 and a P/E of 8.11 against an industry P/E of 27.13. It has zero debt and Jio group entities hold 74.9%. Revenue has been broadly flat and FY26 profit was lower than FY25, which explains part of the discount. It may suit value investors who are comfortable waiting for growth to return.

What does Syncom Formulations do?

Ans. Syncom Formulations makes pharmaceutical formulations, including tablets, capsules and liquids, for domestic and export markets. Its FY26 profit rose 54.6% to Rs 76.44 crore, and September 2026 quarter profit rose 60.5% to Rs 26.65 crore. The company has a debt-to-equity ratio of 0.03 and a return on equity of 20.34%. At Rs 22.09 it trades at a P/E of 21.66, about half the pharma industry average.

Can debt-free companies still be risky?

Ans. Yes, debt-free companies can still face risks such as slowing demand, rising raw material costs, competition and narrowing margins. Their share prices also move with market sentiment, especially at lower price levels. For example, Fineotex and Grauer & Weil have both seen operating margins ease recently. Debt-free status removes financial risk from borrowing, but investors should still review quarterly results and valuation.

How do I check if a stock is debt free?

Ans. Check the debt-to-equity ratio in the company’s latest balance sheet or on a stock screener. A ratio of zero or very close to zero means the company has little or no borrowing relative to its equity. Also look at finance costs in the profit and loss statement, which should be minimal. The Univest Screener lets you filter stocks by debt-to-equity along with price and profit growth.



Debt free stocks Penny Stocks
Author: Ankit Jaiswal
Ankit Jaiswal is the Senior Research Analyst at Univest, leading the platform's in-house equity research desk and serving as the editorial reviewer for all research and blog content published at univest.in. With 11+ years of experience in Indian equity markets, he oversees stock recommendations, earnings analysis, sector coverage, and ensures every published article meets SEBI Research Analyst Regulations. He holds a Bachelor of Commerce (B.Com) from St. Xavier's College, Kolkata — one of India's most prestigious commerce institutions — and has cleared CMT Level 2 from the CMT Association, a globally recognised certification in technical analysis and market research. His research methodology combines fundamental analysis (earnings quality, balance sheet strength, management commentary) with advanced technical analysis (chart patterns, momentum indicators, market structure) — giving Univest's retail investors a dual-lens approach that most Indian research platforms lack. Ankit is among the most comprehensively certified analysts in Indian financial media, holding five NISM certifications: Series-XV (Research Analyst), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-VI (Depository Operations), and Series-V-A (Mutual Fund Distributors). At Univest — India's SEBI-registered research and advisory platform — Ankit's responsibilities include leading the research team, finalising stock recommendations published across Pro Lite, Pro Super, and Pro Gold advisory services, and maintaining editorial oversight of all YMYL financial content published on the blog.

Leave a Reply Cancel reply